AGT and Hypertension: To further reveal the role of CD38 in hypertension in vivo, we used 2 strategies, including using CD38 knockout (KO) mice and CD38 inhibitors in AngII-induced hypertensive mice (Fig. 6a and Supplementary Fig. S19).